Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Globe Life Inc.

Start price
Target price
Perf. (%)
€53.00
15.04.24
-
12.04.25
13.21%
17.04.24

Enlivex Therapeutics Ltd.

Start price
Target price
Perf. (%)
€1.24
15.04.24
-
12.04.25
12.90%
18.04.24

D-wave Quantum Inc.

Start price
Target price
Perf. (%)
€1.45
15.04.24
€3.00
22.03.25
12.18%
17.04.24

buy
Marinus Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.50
15.04.24
-
15.04.25
-12.67%
27.04.24

buy
Viracta Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.81
15.04.24
€3.00
31.10.25
-
15.04.24

Could be very worthwhile Investment >20% year
Delticom AG

Start price
Target price
Perf. (%)
€2.06
15.04.24
-
15.04.25
22.33%
27.04.24

High valuation
Probably not worthwhile Investment
Low dividend yield expected
negative Cash Flow expected
Fair Value Reit-Ag

Start price
Target price
Perf. (%)
€3.66
15.04.24
-
15.04.25
2.73%
27.04.24

Medium risks for its business
negative Cash Flow expected
EBIT decline/stagnation expected
Increased challenges to pay loans and raise capital
buy
Alba SE

Start price
Target price
Perf. (%)
€10.50
15.04.24
€15.00
15.04.25
0.00%
27.04.24

Revenue growth >5% per year expected
Future proof or reliable business model
EBIT growth >5% per year expected
Top 10 in its market
buy
D-wave Quantum Inc.

Start price
Target price
Perf. (%)
€1.54
15.04.24
-
15.04.25
-13.13%
27.04.24

Could be worthwhile Investment >10% per year
Normal challenges to pay loans and raise capital
EBIT growth >5% per year expected
High dividend yield expected
buy
Coupang Inc.

Start price
Target price
Perf. (%)
€20.35
15.04.24
€33.00
15.04.25
6.41%
27.04.24

positive Cash Flow expected
Could be worthwhile Investment >10% per year
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
Fortuna Silver Mines Inc.

Start price
Target price
Perf. (%)
€4.38
15.04.24
-
15.04.25
0.89%
27.04.24

Coeur Mining Inc.

Start price
Target price
Perf. (%)
€4.61
15.04.24
-
15.04.25
-1.39%
27.04.24

First Majestic Silver Corp.

Start price
Target price
Perf. (%)
€7.34
15.04.24
-
15.04.25
-10.63%
27.04.24

Endeavour Silver Corp.

Start price
Target price
Perf. (%)
€2.75
15.04.24
-
15.04.25
-3.93%
27.04.24

Hecla Mining Corp.

Start price
Target price
Perf. (%)
€5.24
15.04.24
-
15.04.25
-9.72%
27.04.24

buy
Annovis Bio Inc.

Start price
Target price
Perf. (%)
€11.10
15.04.24
-
15.04.25
45.95%
28.04.24

buy
Msp Recovery Inc.

Start price
Target price
Perf. (%)
€1.06
15.04.24
-
15.04.25
-11.79%
28.04.24

B2gold Corp.

Start price
Target price
Perf. (%)
€2.74
15.04.24
-
15.04.25
-14.17%
25.04.24

Could be very worthwhile Investment >20% year
Below average Marketposition
Very high cyclical dependencies
Unknown brand
Annovis Bio Inc.

Start price
Target price
Perf. (%)
€11.10
14.04.24
-
14.04.25
45.95%
28.04.24

buy
Adicet Bio Inc.

Start price
Target price
Perf. (%)
€1.97
14.04.24
-
14.04.25
-14.53%
28.04.24

Could be worthwhile Investment >10% per year
buy
aTyr Pharma Inc

Start price
Target price
Perf. (%)
€1.66
14.04.24
-
14.04.25
-10.24%
28.04.24

Could be worthwhile Investment >10% per year
buy
D-wave Quantum Inc.

Start price
Target price
Perf. (%)
€1.50
14.04.24
€1.00
14.04.25
12.53%
17.04.24

Fair valuation
Small cyclical dependencies
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Enlivex Therapeutics Ltd.

Start price
Target price
Perf. (%)
€1.51
14.04.24
-
14.04.25
-9.27%
28.04.24

buy
Globe Life Inc.

Start price
Target price
Perf. (%)
€55.50
14.04.24
-
14.04.25
27.03%
27.04.24

Could be worthwhile Investment >10% per year
buy
Liberty Media Corp.

Start price
Target price
Perf. (%)
€24.00
14.04.24
-
14.05.24
-0.83%
16.04.24